Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s):  SZLSF

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is engaged in improving the early detection and management of cancer and other chronic diseases through diagnostics and telehealth programs that provide clinical interventions to assist patients who have cancer (COC Protocol), and help patients reduce the risk of developing late-stage disease (AVRT). Its test, Aristotle, is the first mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. Aristotle uses mRNA technology to identify the molecular signatures of multiple cancer types and is built on the Company's patented technology platform, the Sentinel Principle. The Care Oncology Clinic offers a supervised treatment regimen (the COC Protocol) for people diagnosed with cancer of any type or stage. Its ColonSentry is a proprietary blood test for screening for Colorectal Cancer.


TSX:SZLS - Post by User

Bullboard Posts
Post by wildbird1on Mar 12, 2019 10:33am
213 Views
Post# 29472697

Credibility is back...

Credibility is back...Many posters on this board keep asking, why with such good cancer tests Genenews didn't progress in value in the last few years.

For a new companies like Genenews, the learning process can sometime be very difficult, sometime you make mistakes that can take years to correct.

That was the case with Genenews a few years ago when Genenews in order to increase its tests revenue made a very bad mistake when it did enter into a partnership with HDL (Health Diagnostics Laboratory).

I can't tell you the whole story, it would be to complicated, but it can be summed in one word ''SCAM'', HDL was a scam.

Genenews wasn't alone many honest company got cought in this scam.

Although Genenews had nothing to do with the scam, unfortunately when your name is associated with a scam you lose credibility.

-You lose credibility with your clients base..
-You lose credibility with Medicare...
-You lose credibility with big HealthCare systems...
-Most of all you lose credibility with Insurance Company..(that was the biggest lost)

The result is that it took years for Genenews to restructure (including changing for a new Billing Company) this process took time.

You can have the best cancer tests in the world (like GEN) if you have no credibility it will be almost impossible to sell your tests.

Question???

How do we know that credibility is back??? 

On Dec 28, 2018 the Insurance Company gave Genenews a Confidence vote (wasn't the case 4 years ago).
PressRelease Dec 28, 2018 Genenews said (QUOTE) Genenews expands coverage by Commercial Health Insurance networks (END of QUOTE).

It took 4 years, but Genenews finally did regain its credibility...

You can be assured that Insurance Company are just the first step...many more will come on board.

Following this vote of confidence from Insurance Company, the big volume and the sp increase (500%) indicate that Genenews credibility is back.

With its credibility back, there is only one direction for Genenews to go, and it is fast forward.


Bullboard Posts